Gestational diabetes menu Diabetes mellitus type 2 is a chronic, progressive disease that cannot now be cured. Gestational diabetes recipe
Some chemicals and drugs specifically destroy pancreatic cells. In one variant of this procedure, Islet cells are injected into the patient's liver, where they take up residence and begin to produce insulin. This is a more plex problem than type 1, but is sometimes easier to treat, especially in the initial years when insulin is often still being produced internally. Gestational diabetes menu. Basic diabetes information
Diabetes mellitus type 2 is presently of unknown etiology (ie, origin). Gestational diabetes menu. Diabetes mellitus with a known etiology, such as secondary to other diseases, known gene defects, trauma or surgery, or the effects of drugs, is more appropriately called secondary diabetes mellitus. The first goal can be achieved through close glycemic control (ie, blood glucose levels); the reduction effect in diabetic plications has been well demonstrated in several extensive clinical trials and is thus well established. Diabetes mellitus type 2 is presently of unknown etiology (ie, origin). There is also a strong inheritable geic connection in type 2 diabetes: having relatives (especially first degree) with type 2 is a considerable risk factor for developing type 2 diabetes. Vacor (N-3-pyridylmethyl-N'-p-nitrophenyl urea), a rodenticide introduced in the United States in 1975, selectively destroys pancreatic beta cells, resulting in Type 1 diabetes after accidental or intentional ingestion. It is also often connected to obesity, which is found in approximately 85% of (North American) patients diagnosed with this type, so some experts believe that inheriting a tendency toward obesity also contributes. The World Health Organization recognizes three main forms of diabetes: type 1, type 2 and gestational diabetes (or type 3, occurring during pregnancy) [1], although these share signs and symptoms but have different causes and population distributions. Cancer survivors who received allogenic Hematopoeitic Cell Transplantation (HCT) are 3.65 times more likely to report type 2 diabetes than their siblings. The current remended goal for HbA1c in patients with diabetes is <7.0%, as defined as "good glycemic control", although some guidelines are stricter (<6.5%). It is also often connected to obesity, which is found in approximately 85% of (North American) patients diagnosed with this type, so some experts believe that inheriting a tendency toward obesity also contributes. |